Euda Health Holdings Limited Quick Ratio (EUDA) starting from the fourth quarter 2025 to fourth quarter 2024, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Euda Health Holdings Limited  (NASDAQ: EUDA)

Euda Health Holdings Limited's Quick Ratio

EUDA's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Current Liabilities decreased faster than Euda Health Holdings Limited's Cash & cash equivalent, this led to improvement in Euda Health Holdings Limited's Quick Ratio to 0.07, Quick Ratio remained below Euda Health Holdings Limited average.

Within Medical Equipment & Supplies industry 208 other companies have achieved higher Quick Ratio than Euda Health Holdings Limited in fourth quarter 2025. While Quick Ratio total ranking in the fourth quarter 2025 has deteriorated compared to the prior quarter from 3997 to 4418.

Explain Quick Ratio?
How much Cash & cash equivalents EUDA´s has?
What are EUDA´s Current Liabilities?




EUDA Quick Ratio (Dec 31 2025)
Q4
0
Q3
0
Q2
0
Q1
(Dec 31 2024)
Q4
Y / Y Current Liabilities Change -23.11 % 40.91 % -41.67 % 40.91 % -37.14 %
Y / Y Cash & cash equivalent Change 45.26 % 45.26 % -53.06 % 45.26 % 25.71 %
Quick Ratio MRQ 0.07 0.06 0.03 0.06 0.04
EUDA's Total Ranking # 4418 # 3997 # # #
Seq. Current Liabilities Change -12.59 % 15.4 % -13.35 % -12.04 % 60.19 %
Seq. Cash & cash equivalent Change 0 % 95.46 % -48.84 % 45.26 % 0 %



Quick Ratio fourth quarter 2025 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 209
Healthcare Sector # 943
Overall Market # 4418


Quick Ratio Statistics
High Average Low
1.47 0.18 0
(Jan 31 2022)   (Dec 31 2022)




Financial Statements
Euda Health Holdings Limited's Current Liabilities $ 5 Millions Visit EUDA's Balance sheet
Euda Health Holdings Limited's Cash & cash equivalent $ 0 Millions Visit EUDA's Balance sheet
Source of EUDA's Sales Visit EUDA's Sales by Geography


Cumulative Euda Health Holdings Limited's Quick Ratio

EUDA's Quick Ratio for the trailling 12 Months

EUDA Quick Ratio

(Dec 31 2025)
12 Months
0
12 Months
0
12 Months
0
12 Months
(Dec 31 2024)
12 Months
Y / Y Current Liabilities TTM Growth -7.45 % -15.06 % -32.46 % -21.32 % -44.55 %
Y / Y Cash & cash equivalent TTM Growth 11.29 % 6.16 % 0.52 % 48.71 % -22.45 %
Quick Ratio TTM 0.06 0.05 0.05 0.05 0.05
Total Ranking TTM # 4758 # 3755 # # #
Seq. Current Liabilities TTM Growth -6.56 % 7.82 % -14.29 % 7.18 % -14.25 %
Seq. Cash & cash equivalent TTM Growth 9.74 % 10.79 % -16.68 % 9.87 % 4.67 %


On the trailing twelve months basis EUDA Cash & cash equivalent soared by 45.26 % in Q4 2025 year on year, while Current Liabilities fell to $5 millions, this led to increase in in Euda Health Holdings Limited's Quick Ratio to 0.06, Quick Ratio remained below EUDA average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 225 other companies have achieved higher Quick Ratio than Euda Health Holdings Limited. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2025 from 3755 to 4758.

Explain Quick Ratio?
How much Cash & cash equivalents EUDA´s has?
What are EUDA´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 226
Healthcare Sector # 1012
Within the Market # 4758


trailing twelve months Quick Ratio Statistics
High Average Low
0.3 0.06 0.02
(Jul 31 2022)  




Companies with similar Quick Ratio in the quarter ending Dec 31 2025, within Medical Equipment & Supplies Industry Quick RatioDec 31 2025 MRQ Cash & cash equivalentDec 31 2025 MRQ Current Liabilities
Infusystem Holdings Inc  0.16 $ 3.186  Millions$ 20.182  Millions
Allurion Technologies Inc   0.14 $ 5.412  Millions$ 38.445  Millions
Ss Innovations International Inc  0.12 $ 3.206  Millions$ 26.242  Millions
Bellevue Life Sciences Acquisition Corp  0.12 $ 1.700  Millions$ 14.127  Millions
The Pennant Group Inc   0.12 $ 17.024  Millions$ 147.264  Millions
Baird Medical Investment Holdings Limited  0.11 $ 0.859  Millions$ 7.539  Millions
The Cooper Companies Inc   0.11 $ 110.600  Millions$ 984.900  Millions
Vivos Therapeutics Inc   0.11 $ 2.029  Millions$ 18.076  Millions
Pavmed Inc   0.11 $ 1.538  Millions$ 14.264  Millions
Northview Acquisition Corp  0.11 $ 1.778  Millions$ 16.525  Millions
Nexgel Inc   0.11 $ 0.317  Millions$ 2.956  Millions
Becton Dickinson And Company  0.10 $ 859.000  Millions$ 8,313.000  Millions
Nakamoto Inc   0.10 $ 21.070  Millions$ 215.162  Millions
National Vision Holdings Inc   0.09 $ 38.708  Millions$ 412.408  Millions
Integer Holdings Corporation  0.08 $ 17.161  Millions$ 222.942  Millions
Biotricity Inc   0.07 $ 1.425  Millions$ 20.636  Millions
Euda Health Holdings Limited  0.07 $ 0.345  Millions$ 5.101  Millions
Petvivo Holdings Inc   0.06 $ 0.255  Millions$ 4.317  Millions
Enovis Corp  0.06 $ 36.389  Millions$ 625.652  Millions
Agape Atp Corporation  0.05 $ 0.140  Millions$ 2.732  Millions
P3 Health Partners Inc   0.05 $ 25.012  Millions$ 503.219  Millions
Henry Schein Inc   0.05 $ 156.000  Millions$ 3,150.000  Millions
Stimcell Energetics Inc   0.04 $ 0.015  Millions$ 0.349  Millions
Dror Ortho-Design, Inc.  0.04 $ 0.080  Millions$ 2.267  Millions
Mountain Crest Acquisition Corp V  0.03 $ 0.012  Millions$ 0.353  Millions
Catheter Precision Inc   0.02 $ 0.088  Millions$ 3.907  Millions
Vycor Medical Inc   0.02 $ 0.093  Millions$ 4.782  Millions

Date modified: 2026-07-07T10:43:22+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.